Ir directamente a la navegación principal Ir directamente a la búsqueda Ir directamente al contenido principal

Do baseline participant characteristics impact the effectiveness of a mobile health intervention for depressive symptoms? A post-hoc subgroup analysis of the CONEMO trials

  • Heloísa Garcia Claro
  • , Paulo Rossi Menezes
  • , Ivan Filipe Fernandes
  • , Nadine Seward
  • , Juan Jaime Miranda
  • , Maria Giovana Borges Saidel
  • , Aline Geovanna de Lima Baquete
  • , Kate L. Daley
  • , Suzana Aschar
  • , Daniela Vera Cruz
  • , Hellen Carolina Martins Castro
  • , Thais Rocha
  • , Julieta Quayle
  • , Tim J. Peters
  • , Ricardo Araya
  • Faculdade de Enfermagem
  • University of Campinas
  • University of São Paulo
  • Departamento de Medicina Preventiva
  • Centro de Engenharia
  • Federal University of ABC
  • Centre for Global Mental Health and Primary Care Research
  • King’s College London
  • University of Bristol

Producción científica: Contribución a una revistaArtículorevisión exhaustiva

1 Cita (Scopus)

Resumen

Objective: To ascertain whether sociodemographic and health-related characteristics known from previous research to have a substantive impact on recovery from depression modified the effect of a digital intervention designed to improve depressive symptoms (CONEMO). Methods: The CONEMO study consisted of two randomized controlled trials, one conducted in Lima, Peru, and one in São Paulo, Brazil. As a secondary trial plan analysis, mixed logistic regression was used to explore interactions between the treatment arm and subgroups of interest defined by characteristics measured before randomization – suicidal ideation, race/color, age, gender, income, type of mobile phone, alcohol misuse, tobacco use, and diabetes/hypertension – in both trials. We estimated interaction effects between the treatment group and these subgroup factors for the secondary outcomes using linear mixed regression models. Results: Increased effects of the CONEMO intervention on the primary outcome (reduction of at least 50% in depressive symptom scores at 3-month follow-up) were observed among older and wealthier participants in the Lima trial (p = 0.030 and p = 0.001, respectively). Conclusion: There was no evidence of such differential effects in São Paulo, and no evidence of impact of any other secondary outcomes in either trial. Clinical trial registration: NCT02846662 (São Paulo, Brazil – SP), NCT03026426 (Lima, Peru – LI). Funded by the U.S. National Institute of Mental Health (grant U19MH098780).

Idioma originalInglés
Número de artículoe20233172
PublicaciónBrazilian Journal of Psychiatry
Volumen46
DOI
EstadoPublicada - 2024
Publicado de forma externa

ODS de las Naciones Unidas

Este resultado contribuye a los siguientes Objetivos de Desarrollo Sostenible

  1. ODS 3: Salud y bienestar
    ODS 3: Salud y bienestar

Citar esto